GL1X · GenesisL1 explorer

Ligand · 8H9

8H9 · (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-(hexylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

8H9, (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-(hexylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide (C33 H58 N6 O6, 634.9 g/mol), in the…

Component
8H9
Formula
C33 H58 N6 O6
Class
ligand
Structures
2
PDB entries
1

Binding sites

8H9 in 2 structures; the first of them:

  • 7S71 · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI35 · 8H9 A401 · binds THR25, THR26, LEU27, HIS41, TYR54, PHE140, LEU141, ASN142 and 15 more
  • 7S71 · Structure of the SARS-cov-2 main protease in complex with inhibitor MPI35 · 8H9 A401 · binds THR25, THR26, HIS41, PHE140, ASN142, GLY143, SER144, CYS145 and 10 more

Residues it binds most

HIS 2, THR 2, GLN 2, LEU 2, ARG 2, ASN 2, CYS 2, GLU 2, GLY 2, MET 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.